Human mouse chimeric CD7 monoclonal antibody (SDZCHH380) for the prophylaxis of kidney transplant rejection: analysis beyond 4 years.
Sharma
L C
LC
Multi-Organ Transplant Service, London Health Sciences Centre, Robarts Research Institute, Canada.
Muirhead
N
N
Lazarovits
A I
AI
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003404:Creatinine / Q000097:blood; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000517:prevention & control*; D006801:Humans; D007165:Immunosuppression Therapy; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D051379:Mice; D016853:Muromonab-CD3 / Q000627:therapeutic use; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use; D013997:Time Factors
D000911:Antibodies, Monoclonal; D016853:Muromonab-CD3; D011993:Recombinant Fusion Proteins; C079847:SDZ CHH 380; D003404:Creatinine